| Shortening the timeline of pediatric phase I trials: the rolling six design JM Skolnik, JS Barrett, B Jayaraman, D Patel, PC Adamson Journal of Clinical Oncology 26 (2), 190-195, 2008 | 265 | 2008 |
| MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. K Peerlinck, I De Lepeleire, M Goldberg, D Farrell, J Barrett, E Hand, ... Circulation 88 (4), 1512-1517, 1993 | 253 | 1993 |
| Population pharmacokinetic studies in pediatrics: issues in design and analysis B Meibohm, S Läer, JC Panetta, JS Barrett The AAPS journal 7, E475-E487, 2005 | 206 | 2005 |
| Physiologically based pharmacokinetic (PBPK) modeling in children JS Barrett, O Della Casa Alberighi, S Läer, B Meibohm Clinical Pharmacology & Therapeutics 92 (1), 40-49, 2012 | 201 | 2012 |
| Pharmacokinetics and pharmacodynamics of MK‐383, a selective non‐peptide platelet glycoprotein‐IIb/IIIa receptor antagonist, in healthy men JS Barrett, G Murphy, K Peerlinck, ID Lepeleire, RJ Gould, D Panebianco, ... Clinical Pharmacology & Therapeutics 56 (4), 377-388, 1994 | 181 | 1994 |
| Population pharmacokinetics of fluconazole in young infants KC Wade, D Wu, DA Kaufman, RM Ward, DK Benjamin Jr, JE Sullivan, ... Antimicrobial agents and chemotherapy 52 (11), 4043-4049, 2008 | 155 | 2008 |
| Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings JS Barrett, MJ Fossler, KD Cadieu, MR Gastonguay The Journal of Clinical Pharmacology 48 (5), 632-649, 2008 | 148 | 2008 |
| Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6 BJ Gertz, JS Barrett, R Eisenhandler, DA Krupa, JM Wittreich, JR Seibold, ... The Journal of Clinical Endocrinology & Metabolism 77 (5), 1393-1397, 1993 | 145 | 1993 |
| Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization JS McCune, MJ Bemer, JS Barrett, K Scott Baker, AS Gamis, NHG Holford Clinical Cancer Research 20 (3), 754-763, 2014 | 143 | 2014 |
| Moricizine bioavailability via simultaneous, dual, stable isotope administration: bioequivalence implications HJ Pieniaszek Jr, M Mayersohn, MP Adams, RJ Reinhart, JS Barrett The Journal of Clinical Pharmacology 39 (8), 817-825, 1999 | 136 | 1999 |
| Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis X Zuo, CM Ng, JS Barrett, A Luo, B Zhang, C Deng, L Xi, K Cheng, Y Ming, ... Pharmacogenetics and genomics 23 (5), 251-261, 2013 | 135 | 2013 |
| Population pharmacokinetics and pharmacodynamics of ciclesonide S Rohatagi, V Arya, K Zech, R Nave, G Hochhaus, BK Jensen, JS Barrett The Journal of Clinical Pharmacology 43 (4), 365-378, 2003 | 135 | 2003 |
| A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms A Zajicek, MJ Fossler, JS Barrett, JH Worthington, R Ternik, G Charkoftaki, ... The AAPS journal 15, 1072-1081, 2013 | 125 | 2013 |
| Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography–electrospray ionization mass spectrometry JI Lee, M Narayan, JS Barrett Journal of Chromatography B 845 (1), 95-103, 2007 | 125 | 2007 |
| Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography–electrospray tandem mass spectrometry JI Lee, BH Hsu, D Wu, JS Barrett Journal of Chromatography A 1116 (1-2), 57-68, 2006 | 125 | 2006 |
| Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study JW Hainer, JS Barrett, CA Assaid, MJ Fossler, DS Cox, T Leathers, ... Thrombosis and haemostasis 87 (05), 817-823, 2002 | 121 | 2002 |
| Application of physiologically based pharmacokinetic modeling to predict acetaminophen metabolism and pharmacokinetics in children XL Jiang, P Zhao, JS Barrett, LJ Lesko, S Schmidt CPT: pharmacometrics & systems pharmacology 2 (10), 1-9, 2013 | 118 | 2013 |
| Population pharmacokinetic meta-analysis with efavirenz. JS Barrett, AS Joshi, M Chai, TM Ludden, WD Fiske, HJ Pieniaszek Jr International journal of clinical pharmacology and therapeutics 40 (11), 507-519, 2002 | 115 | 2002 |
| Innovative clinical trial design for pediatric therapeutics MM Laughon, DK Benjamin, EV Capparelli, GL Kearns, K Berezny, ... Expert review of clinical pharmacology 4 (5), 643-652, 2011 | 114 | 2011 |
| A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam AR Maharaj, JS Barrett, AN Edginton The AAPS journal 15, 455-464, 2013 | 112 | 2013 |
Peter C. AdamsonChildren's Hospital of Philadelphia/UPennVerified email at email.chop.edu
